[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354136-105":59,"doc-detail-354136-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","risk-of-late-recurrence-of-colorectal-and-breast-cancer-among-older-long-term-cancer-survivors","Risk of late recurrence of colorectal and breast cancer among older long-term cancer survivors","","Growing numbers of older cancer survivors face both cancer and noncancer health risks, yet recurrence patterns beyond 5 years are poorly characterized in routine care. A SEER-Medicare retrospective cohort study evaluated patients aged ≥66 with stage I-III breast, colon, or rectal cancer who survived ≥5 years without recurrence or second primary malignancy. Late treated recurrence (5–10 years) was measured using claims-based algorithms and predictors assessed via RMST regression.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/risk-of-late-recurrence-of-colorectal-and-breast-cancer-among-older-long-term-cancer-survivors/354136/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/risk-of-late-recurrence-of-colorectal-and-breast-cancer-among-older-long-term-cancer-survivors/354136.png","ImageObject",300,407,{"name":92,"@type":93},"Rizky","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What population was studied in the SEER-Medicare analysis?","Question",{"text":112,"@type":113},"Patients aged ≥66 with stage I–III breast, colon, or rectal cancer who received definitive surgery and survived ≥5 years from diagnosis without recurrence or a second primary malignancy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was late recurrence defined and identified?",{"text":117,"@type":113},"Late treated recurrence was defined as recurrence occurring 5–10 years after diagnosis and was identified using a validated algorithm applied to Medicare claims.",{"name":119,"@type":110,"acceptedAnswer":120},"Which clinical factors were associated with late treated recurrence?",{"text":121,"@type":113},"Stage consistently predicted shorter RMST; other associations included higher grade, node-positive, and ER-positive disease for breast, left-sided tumors for colon, and radiation for rectal cancer, though effect sizes on RMST were modest (\u003C5%).",{"name":123,"@type":110,"acceptedAnswer":124},"What were the study’s main findings about the frequency of late recurrence and mortality?",{"text":125,"@type":113},"Cumulative incidence of late treated recurrence was 5.0% for breast, 4.4% for colon, and 8.0% for rectal cancer survivors (5–10 years). Incidence of other-cause mortality (24.1%–34.0%) exceeded cancer-specific mortality (2.9%–6.2%).","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},354136,1790144690,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},962085564807,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","JNCI Cancer Spectrum, 2026, 10(3), pkag002  \n[https://doi.org/10.1093/jncics/pkag002](https://doi.org/10.1093/jncics/pkag002)  \nAdvance Access Publication Date: January 7, 2026  \nArticle  \nRisk of late recurrence of colorectal and breast cancer among older long-term cancer survivors  \nFaiza Yasin , MD, MHS1, Sarah J. Westvold , MPH2,3, Jessica B. Long, MPH2, 3, Terry Hyslop , PhD4, Michael Cecchini , MD1, Ira Leeds , MD, MBA2, 5, Andrea Silber , MD1, Shi-Yi Wang , MD, PhD2,6, Lisa Spees , PhD7,8, Rebecca Forman, MD1, Tendai Kwaramba , MD, MSc1, Melissa Taylor , MD, MPH1, Cary P. Gross , MD2, 3, Michaela A. Dinan , PhD􀀃 ,2 ,6 1Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, United States  \n2Yale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, New Haven, CT, United States 3Department of Medicine (Internal Medicine), Yale School of Medicine, New Haven, CT, United States  \n4Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University, Philadelphia, PA, United States 5Department of Surgery (Colon and Rectal Surgery), Yale School of Medicine, New Haven, CT, United States 6Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, United States 7Lineberger Comprehensive Cancer Center (UNC-CH), Chapel Hill, NC, United States  \n8Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, UNC-CH, Chapel Hill, NC, United States  \n􀀃 Corresponding author: Michaela A. Dinan, PhD, Department of Chronic Disease Epidemiology, Yale School of Public Health, P. O. Box 208034, 60 College St, New Haven, CT 06420, United States ([michaela.dinan@yale.edu](michaela.dinan@yale.edu)) .  \nAbstract  \nBackground: A growing population of older adult cancer survivors faces competing cancer and noncancer health risks. There are limited real-world data on recurrence patterns beyond 5 years post-treatment.  \nMethods: This was a SEER-Medicare retrospective cohort study of patients aged ≥66 with stage I-III breast, colon, or rectal cancer who received definitive surgery and survived ≥5 years from diagnosis without recurrence or second primary malignancy. Late recurrence (5–10 years postdiagnosis) was identified using a validated algorithm to detect treated recurrence in Medicare claims. Demographic and clinical characteristics collected at cancer diagnosis were assessed as predictors of late treated recurrence using restricted mean survival time (RMST) regression.  \nResults: The sample included 12 859 breast, 17 329 colon, and 4427 rectal cancer survivors. The cumulative incidence of late treated recurrence 5-10 years postdiagnosis was 5.0% in breast, 4.4% in colon, and 8.0% in rectal cancer survivors. In all cohorts, stage was associated with shorter RMST. The absolute risk difference between stage I and III was greatest in breast (2% vs 18.1%), followed by rectal (5.2% vs 10.3%) and colon (2.7% vs 6.7%) cancer survivors (P \u003C .001 for all cohorts) . Although their effect on RMST was modest (\u003C5%), higher grade, node-positive, and ER-positive disease in breast, left-sided tumors in colon, and radiation in rectal cancer were associated with late treated recurrence. Across all cohorts, the incidence of other-cause mortality (24.1%-34.0%) exceeded cancerspecific mortality (2.9%-6.2%) .  \nConclusions: Late treated recurrence in older long-term survivors is uncommon, but risk remains elevated 5 years postdiagnosis in those with more advanced stage.  \nBackground  \nAdvances in cancer detection and treatment have led to a growing population of long-term cancer survivors,1-3 many of whom are older adults facing both cancer and noncancer health risks.4-6 Older adults are at significantly higher risk of developing invasive cancer compared with their younger counterparts.7 Cancer recurrence risk is a major factor in determining standards for surveillance after completion of definitive cancer-directed therapy. Surveillance guidelines for breast and colorectal ","cbCaisNLfw4sSlgF","https://ap.wps.com/l/cbCaisNLfw4sSlgF","pdf",1695905,11,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Background\n# Received, Revised, Accepted and Publication Details","[{\"question\":\"What population was studied in the SEER-Medicare analysis?\",\"answer\":\"Patients aged ≥66 with stage I–III breast, colon, or rectal cancer who received definitive surgery and survived ≥5 years from diagnosis without recurrence or a second primary malignancy.\"},{\"question\":\"How was late recurrence defined and identified?\",\"answer\":\"Late treated recurrence was defined as recurrence occurring 5–10 years after diagnosis and was identified using a validated algorithm applied to Medicare claims.\"},{\"question\":\"Which clinical factors were associated with late treated recurrence?\",\"answer\":\"Stage consistently predicted shorter RMST; other associations included higher grade, node-positive, and ER-positive disease for breast, left-sided tumors for colon, and radiation for rectal cancer, though effect sizes on RMST were modest (\\u003c5%).\"},{\"question\":\"What were the study’s main findings about the frequency of late recurrence and mortality?\",\"answer\":\"Cumulative incidence of late treated recurrence was 5.0% for breast, 4.4% for colon, and 8.0% for rectal cancer survivors (5–10 years). Incidence of other-cause mortality (24.1%–34.0%) exceeded cancer-specific mortality (2.9%–6.2%).\"}]","Risk of late recurrence of colorectal and breast cancer among older long-term cancer survivors | PDF",1790109184,28,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8c9282d679d2e6b6b4553e0db4f77fcf.webp",983,1291,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b69d571d06825d07a51d3446ca8c9fb3.webp",982,1290,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6ad470415c1dfb63d717c7ea2b7f4e27.webp",981,1289,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/afd1f85adb5ddb4f8a23527514e41d22.webp",980,1287]